cas 89897-29-0|| where to buy 3-amino-1-propan-2-ylpyrazole-4-carbonitrile

製品名:3-amino-1-propan-2-ylpyrazole-4-carbonitrile

IUPAC Name:3-amino-1-(propan-2-yl)-1H-pyrazole-4-carbonitrile

包装単位	有効在庫	価格（USD）
CM336694-1g	in stock	ŌŤƚ
CM336694-5g	in stock	ǙŌľ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 89897-29-0 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:89897-29-0; 分子式:C7H10N4; 融点:-; SMILESコード:N#CC1=CN(C(C)C)N=C1N; 密度:

: Pyrazoles; Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.; Pyrazone; Custom pyrazone for customers from all over the world are our main business.

: Encorafenib plus Binimetinib; U.S. FDA approved Pfizer's BRAFTOVI® (Encorafenib) + MEKTOVI® (Binimetinib) for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation. The FDA's approval is based on data from the ongoing Phase 2 PHAROS clinical trial. Encorafenib is an oral small molecule BRAF kinase inhibitor, and Binimetinib is an oral small molecule MEK inhibitor targeting key proteins in the MAPK signaling pathway (RAS-RAF-MEK-ERK).
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.